Robert Alexander - 03 Jun 2021 Form 4 Insider Report for Allena Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Kevin Brennan, attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 16:00:33 UTC
Previous filing
04 Jun 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNAQ Stock Option (Right to Buy) Award $0 +37,000 $0.000000 37,000 03 Jun 2021 Common Stock 37,000 $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option shall vest in full (i.e., in single installment) upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.